/IBRX

Immunitybio Inc

IBRX

$7.91USD↑+2.46%+0.19 today

MARKET CAP

8.4B

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$8 – $8

52W RANGE

$2

$12

AI Summary

Stalk

StalkMedium

IBRX remains in a Stage 2 consolidation above its rising 200DMA after the mid-Feb parabolic spike and collapse. Short-term EMAs (9/20/50) are flat and price sits slightly below the cluster, with neutral RSI and Options Score signaling no clear timing edge. Medium-term bias stays bullish in this range-bound structure, but execution should await support near the lower range or a decisive reclaim of the EMA cluster.

↑Q2 2026 net revenues $50.7 M, up 92% YoY.
↑ANKTIVA revenues projected to hit $210 M (+85% YoY) in 2026.
↓Negative profitability factors suggest unsustainable margin structure.

Full analysis →

Buying

8

institutions

Selling

6

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕	Action↕	Shares Held↕	Value↓	Change↕	Chg %↕	Weight↕
BI Blackrock, Inc. Q2 2026	BUY	34.08 M	298.40 M	+7.74 M	+47.7%	0.00%
CA Citadel Advisors LLC Q2 2026	BUY	5.67 M	49.68 M	+538.77 K	+26.1%	0.01%
MM Millennium Management LLC Q2 2026	BUY	5.58 M	48.85 M	+4.14 M	+341.1%	0.02%
WP Woodline Partners LP Q2 2026	SELL	2.50 M	21.89 M	+-4.39 M	-58.6%	0.07%
VI Voloridge Investment Management, LLC Q2 2026	SELL	1.72 M	15.08 M	+-1.21 M	-32.9%	0.06%
JC Jpmorgan Chase & Co Q2 2026	SELL	1.45 M	12.87 M	+-39.33 K	+29.8%	0.00%
RT Renaissance Technologies LLC Q2 2026	BUYNEW	1.03 M	9.01 M	+1.03 M	+0.0%	0.01%
JH Janus Henderson Group Plc Q1 2026	BUY	314.88 K	2.41 M	+196.14 K	+926.5%	0.00%
AC Aqr Capital Management LLC Q2 2026	BUY	222.86 K	1.95 M	+156.31 K	+282.3%	0.00%
HS Hussman Strategic Advisors, Inc. Q2 2026	BUYNEW	147.00 K	1.29 M	+147.00 K	+0.0%	0.30%
PA Point72 Asset Management, L.P. Q2 2026	SELL	132.00 K	1.16 M	+-28.10 K	-5.9%	0.00%
BH Brevan Howard Capital Management LP Q2 2026	BUY	85.86 K	751.68 K	+29.19 K	+73.0%	0.01%
BA Balyasny Asset Management L.P. Q2 2026	SELL	83.58 K	731.78 K	+-20.29 K	-8.2%	0.00%
RC Rockefeller Capital Management L.P. Q2 2026	SELL	5.96 K	52.22 K	+-55.00	+13.1%	0.00%